EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non‐ asahii species

Eun Hwa Lee, Min Hyuk Choi, Kyoung Hwa Lee iD, Young Goo Song, Sang Hoon Han iD

Mycoses · 2023

DOI: 10.1111/myc.13635 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Mycoses, 2023. Verfasst von Eun Hwa Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Trichosporonosis, Neutropenia, Trichosporon. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trichosporon is an emerging yeast that causes invasive infections in immunocompromised patients experiencing prolonged hospitalisation, indwelling venous catheters and neutropenia.

Methods

This retrospective observational cohort study analysed invasive Trichosporon infections (ITIs) occurring between January 2005 and December 2022 at three tertiary hospitals and compared the clinical characteristics and prognostic factors of ITIs caused by Trichosporon asahii and non‐ T . asahii spp. After evaluating 1067 clinical isolates, we identified 46 patients with proven ITIs, defined as cases in which Trichosporon was isolated from blood, cerebrospinal fluid, or sterile tissues.

Results

The patients were separated into T . asahii and non‐ T . asahii groups containing 25 and 21 patients, respectively, all of which except one were immunocompromised. During this period, both the number of clinical isolates and patients with ITIs (mainly T . asahii ) increased; whereas, cases involving non‐ T . asahii spp. decreased. Compared with the non ‐ T . asahii group, the T . asahii group had more patients with multiple catheters (84% vs. 33%, p = .001) and those receiving renal replacement therapy (48% vs. 14%, p = .005). The all‐cause 28‐day mortality rate after ITI in the T . asahii group (44%) was significantly higher than in the non‐ T . asahii group (10%, Log‐rank p = .014). The multivariate Cox regression model revealed that T . asahii (reference, non‐ T . asahii spp.; aHR = 4.3; 95% CI = 1.2–15.2, p = .024) and neutropenia for 5 days or more (aHR = 2.2, 95% CI = 1.5–3.6, p = .035) were independent factors in the 28‐day mortality after ITI.

Conclusion

The proven ITIs due to T . asahii produced more unfavourable outcomes compared with ITIs caused by non‐ T . asahii spp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrichosporonosisNeutropeniaTrichosporonRetrospective StudiesAntifungal AgentsHumansBasidiomycota

Stichwörter der Autor:innen

Trichosporon asahiiTrichosporonosisinvasive yeast infectionmortalityspecies

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Kyoung Hwa Lee, Sang Hoon Han

Zitieren

APA

Lee, E. H., Choi, M. H., Lee, K. H., Song, Y. G., & Han, S. H. (2023). Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non‐ asahii species. Mycoses. https://doi.org/10.1111/myc.13635

Vancouver

Lee EH, Choi MH, Lee KH, Song YG, Han SH. Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non‐ asahii species. Mycoses. 2023. doi:10.1111/myc.13635

BibTeX
@article{Lee2023,
  author = {Lee, Eun Hwa and Choi, Min Hyuk and Lee, Kyoung Hwa and Song, Young Goo and Han, Sang Hoon},
  title = {Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non‐ asahii species},
  journal = {Mycoses},
  year = {2023},
  doi = {10.1111/myc.13635}
}
Kostenlos starten →